651 related articles for article (PubMed ID: 7642022)
1. [SFAAT: the study of nonrheumatic chronic atrial fibrillation in the Trieste area. Results of an enrollment study].
Scardi S; Mazzone C; Goldstein D; Pandullo C; Poletti A; Humar F; Pivotti F; De Santis C
G Ital Cardiol; 1995 Feb; 25(2):173-82. PubMed ID: 7642022
[TBL] [Abstract][Full Text] [Related]
2. Mortality and cause of death in patients with chronic non-rheumatic atrial fibrillation after a two-year follow-up.
Scardi S; Mazzone C; Pandullo C; Goldstein D; Di Lenarda A; Chersevani D
G Ital Cardiol; 1999 Jun; 29(6):637-46. PubMed ID: 10396667
[TBL] [Abstract][Full Text] [Related]
3. [A longitudinal study on left atrial thrombosis in patients with non-rheumatic atrial fibrillation treated with anticoagulants].
Scardi S; Mazzone C; Pandullo C; Goldstein D; Perkan A
G Ital Cardiol; 1997 Oct; 27(10):1036-43. PubMed ID: 9359051
[TBL] [Abstract][Full Text] [Related]
4. Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers.
Capucci A; Santini M; Padeletti L; Gulizia M; Botto G; Boriani G; Ricci R; Favale S; Zolezzi F; Di Belardino N; Molon G; Drago F; Villani GQ; Mazzini E; Vimercati M; Grammatico A;
J Am Coll Cardiol; 2005 Nov; 46(10):1913-20. PubMed ID: 16286180
[TBL] [Abstract][Full Text] [Related]
5. Embolic events in 93 elderly Chinese patients with atrial fibrillation.
Cao X; Wang S; Jiang L; Liu L; Huang H; Lu Z
Chin Med J (Engl); 2000 Apr; 113(4):320-3. PubMed ID: 11775227
[TBL] [Abstract][Full Text] [Related]
6. [Study of combined anticoagulant (fluindione)-aspirin therapy in patients with atrial fibrillation at high risk for thromboembolic complications. A randomized trial (FFAACS)].
Lechat P; Lardoux H; Mallet A; Sanchez P; Derumeaux G; Lecompte T; Maillard L; Mas JL; Mentré F; Pousset F; Lacomblez L; Pisica G; Solbes-Latourette S; Raynaud P; Chaumet-Riffaud P;
Therapie; 2000; 55(6):681-9. PubMed ID: 11234463
[TBL] [Abstract][Full Text] [Related]
7. [The best of valvular heart disease in 2006].
de Gevigney G;
Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():19-28. PubMed ID: 17405561
[TBL] [Abstract][Full Text] [Related]
8. Consequence of atrial fibrillation and the risk of embolism after percutaneous mitral commissurotomy: the necessity of the maze procedure.
Nakajima H; Kobayashi J; Bando K; Yasumura Y; Nakatani S; Kimura K; Niwaya K; Tagusari O; Kitamura S
Ann Thorac Surg; 2004 Sep; 78(3):800-5; discussion 805-6. PubMed ID: 15336994
[TBL] [Abstract][Full Text] [Related]
9. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy.
Hohnloser SH; Pajitnev D; Pogue J; Healey JS; Pfeffer MA; Yusuf S; Connolly SJ;
J Am Coll Cardiol; 2007 Nov; 50(22):2156-61. PubMed ID: 18036454
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.
Ruiz-Nodar JM; Marín F; Hurtado JA; Valencia J; Pinar E; Pineda J; Gimeno JR; Sogorb F; Valdés M; Lip GY
J Am Coll Cardiol; 2008 Feb; 51(8):818-25. PubMed ID: 18294566
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice.
Caro JJ; Flegel KM; Orejuela ME; Kelley HE; Speckman JL; Migliaccio-Walle K
CMAJ; 1999 Sep; 161(5):493-7. PubMed ID: 10497604
[TBL] [Abstract][Full Text] [Related]
12. [Frequency and predictors of atrial fibrillation in severe mitral regurgitation].
Duran NE; Duran I; Sönmez K; Gençbay M; Akçay A; Turan F
Anadolu Kardiyol Derg; 2003 Jun; 3(2):129-34. PubMed ID: 12826507
[TBL] [Abstract][Full Text] [Related]
13. [Atrial fibrillation and thromboembolism: a multicenter cooperative study. Research Group for Antiarrhythmic Drug Therapy].
J Cardiol; 1998 Apr; 31(4):227-38. PubMed ID: 9594372
[TBL] [Abstract][Full Text] [Related]
14. Atrial fibrillation, the arrhythmia of the elderly, causes and associated conditions.
Levy S
Anadolu Kardiyol Derg; 2002 Mar; 2(1):55-60. PubMed ID: 12101796
[TBL] [Abstract][Full Text] [Related]
15. [Atrial fibrillation: incidence and prognostic factors of embolic risk].
Di Pasquale G; Ribani MA; Urbinati S; Passarelli P; Pinelli G
Cardiologia; 1993 Dec; 38(12 Suppl 1):291-300. PubMed ID: 8020029
[TBL] [Abstract][Full Text] [Related]
16. Anticoagulation and atrial fibrillation.
Atwood JE; Albers GW
Herz; 1993 Feb; 18(1):27-38. PubMed ID: 8454250
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.
Friberg L; Rosenqvist M; Lip GY
Eur Heart J; 2012 Jun; 33(12):1500-10. PubMed ID: 22246443
[TBL] [Abstract][Full Text] [Related]
18. [Thromboembolic complications of arrhythmia due to atrial fibrillation].
Lekieffre J; Lacroix D; Klug D; Kacet S
Arch Mal Coeur Vaiss; 1994 Sep; 87 Spec No 3():17-23. PubMed ID: 7786120
[TBL] [Abstract][Full Text] [Related]
19. [Oral anticoagulation for prevention of thromboembolism in non-rheumatic atrial fibrillation: indications, effectiveness and risk].
Kottkamp H; Willems S; Hindricks G; Chen X; Haverkamp W; Hasfeld M; Borggrefe M; Breithardt G
Z Kardiol; 1993 Nov; 82(11):667-73. PubMed ID: 8291287
[TBL] [Abstract][Full Text] [Related]
20. [The effects of the ablation of atrial flutter in patients with and without a clinical history of paroxysmal atrial fibrillation].
De Sisti A; Leclercq JF; Fiorello P; Palamara A; Attuel P
G Ital Cardiol; 1998 Nov; 28(11):1253-60. PubMed ID: 9866803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
